Pharma says UK is ‘tumbling down’ rankings for investment
The UK is losing out to competitors in attracting investment in R&D, clinical trials, and capital projects due to a stubborn refusal to pay for innovative new medicines, according to the pharma industry. A report on pharma competitiveness, published by the Association of the British Pharmaceutical Industry (ABPI), claims that the UK’s position for attracting…
